Menu
/REGISTER
Montecito
Tolman Wiker
Pac Premier
Farmers merchants
Loading...
You are here:  Home  >  Biotech  >  Current Article

Amgen partners with Provention Bio on celiac disease treatment

By   /   Monday, November 5th, 2018  /   Comments Off on Amgen partners with Provention Bio on celiac disease treatment

    Print       Email
Thousand Oaks biotech giant Amgen set its sights on the digestive autoimmune disorder known as celiac disease with a $20 million licensing and co-development deal with New Jersey-based Provention Bio. Announced Nov. 5, the partnership will develop an antibody to treat celiac disease that is not responsive to a gluten-free diet, or NRCD. Provention will…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Ventura hard kombucha brewer raises $25 million

Read More →